Forbes Kendall 4

What Happened
Forbes Kendall, Executive Vice President, Sales & Operations of Guardian Pharmacy Services (GRDN), received a grant of 8,952 restricted stock units (RSUs) on March 1, 2026. The award was reported at $0.00 per share (no cash purchase); these RSUs will settle one-for-one into Class A common stock when they vest. The award vests in full on March 1, 2029.

Key Details

• Transaction date: March 1, 2026; Filing date: March 3, 2026 (Form 4 accession 0001193125-26-088191). Filing appears timely.
• Transaction type/code: Award/Grant (Code A). Reported price: $0.00; shares granted: 8,952 RSUs.
• Vesting/footnote: RSUs settle one-for-one into Class A common stock and vest in full on March 1, 2029.
• Shares owned after transaction: Not disclosed on this filing.
• No tax withholding or sale reported in this transaction — this is a grant, not an immediate sale or cash exercise.

Context
RSU grants are a common form of equity compensation for executives and do not require immediate cash outlay; they convert to actual shares only upon vesting (and may be taxable at that time). This award alone does not indicate buying or selling sentiment in the market — it’s a compensation grant subject to the stated vesting schedule.